1 / 3

Biosimulation Market

As the incidence of infectious and chronic diseases is rising, the need for drugs that can help in treating or managing these diseases is increasing. Pharmaceutical companies are constantly conducting research for developing new drugs. Biosimulation software is used for testing the toxicity, efficacy as well as safety of the drugs during development process.

Rachana1
Download Presentation

Biosimulation Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Biosimulation Market Highlighting Regional Revenue Share Dominance by 2031 Biosimulation Market by Products & Services (Software and Services), Application (Drug Discovery and Drug Development), End User (Pharmaceutical & Biotechnology Companies, Contract Research Organization, Regulatory Institutes, and Research Institutes)–Global Outlook & Forecast 2021-2031. According to the deep-dive market assessment study conducted by Growth+ Reports, the global biosimulation market was pegged at ~US$ 2.11 billion in 2020. The market is expected to witness a CAGR of ~15.5% from 2021 to 2031. As the incidence of infectious and chronic diseases is rising, the need for drugs that can help in treating or managing these diseases is increasing. Pharmaceutical companies are constantly conducting research for developing new drugs. Biosimulation software is used for testing the toxicity, efficacy as well as safety of the drugs during development process. Moreover, increasing number of off-patent drugs has led to the rising demand for biosimilars and this is also driving the demand for biosimulation software which are used in simulation studies for biosimilars. The prominent players in the biosimulation market are focused on developing and launching new software in the market. To access the Sample PDF of this research study, please request here: https://growthplusreports.com/inquiry/request-sample/biosimulation-market/7621 The report includes an in-depth study of the global market Biosimulation, where segments and sub- segments are analysed in quite a detail. This research will help players focus on high-growth segments and modify their business strategies if needed. The Biosimulation global market is segmented based on Products, Technology, and End Users. The regional segmentation research presented in the report provides players with valuable insights and data regarding key geographic markets such as North America, Europe, Asia Pacific, and the Rest of the World (RoW). Our researchers and analysts use reliable primary and secondary sources for research and data. Some of the prominent players operating in the global Biosimulation Market include •Certara •Dassault Systemes •Chemical Computing Group ULC •Simulations Plus •Rosa & Co. LLC •Genedata AG •Schrodinger •Physiomics Plc •Inosim Software GmbH •LeadInvent Pharma •among others Table of Contents 1. INTRODUCTION 1. Market Ecosystem 2. Geographic Scope 3. Timeline Under Consideration 1. Historical Years – 2018 & 2019

  2. 2. Base Year – 2020 3. Forecasted Years – 2021 to 2031 4. Currency Used in the Report 2. RESEARCH METHODOLOGY 1. Research Approach 2. Data Collection Methodology 3. Data Sources 1. Secondary Sources 2. Primary Sources 4. Market Estimation Approach 1. Bottom Up 2. Top Down 5. Market Forecasting Model 6. Limitations and Assumptions 3. PREMIUM INSIGHTS 1. Current Market Trend (COVID-19 Perspective) 2. Key Players & Their Competitive Positioning (2020) 4. MARKET DYNAMICS 1. Drivers 2. Restraints/Challenges 3. Opportunities 5. GLOBAL BIOSIMULATION MARKET – ANALYSIS & FORECAST, BY PRODUCTS & SERVICES 1. Software 1. PK/PD Modeling & Simulation 2. PBPK Modeling & Simulation 3. Molecular Modeling 4. Trial Simulators 5. Toxicity Prediction 6. Other Software 2. Services 1. In-house Services 2. Contract Services 6. GLOBAL BIOSIMULATION MARKET – ANALYSIS & FORECAST, BY APPLICATION 1. Drug Discovery 1. Target Identification & Validation 2. Lead Identification & Optimization 2. Drug Development 1. Pre-clinical Testing 2. Clinical Trial 3. Other Applications 7. GLOBAL BIOSIMULATION MARKET – ANALYSIS & FORECAST, BY END USER 1. Pharmaceutical & Biotechnology Companies 2. Contract Research Organization 3. Regulatory Institutes

  3. 4. Research Institutes 5. Other End Users TOC Continued… Browse the full report now: https://growthplusreports.com/report/biosimulation-market/7621 About Us: Growth+Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association). Growth+ portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis, and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success. We were awarded by the prestigious CEO Magazine as "Most Innovative Healthcare Market Research Company in 2020.

More Related